International Journal of Chronic Obstructive Pulmonary Disease
Volume 14, 2019 - Issue
Original Research
Long-term cost and utility consequences of short-term clinically important deterioration in patients with chronic obstructive pulmonary disease: results from the TORCH study
Victoria Federico Paly1 ICON Health Economics, ICON, Philadelphia, PA, USA
https://orcid.org/0000-0003-3508-1296
https://orcid.org/0000-0003-3508-1296, Ian Naya2 Global Respiratory Franchise, GSK, Brentford, Middlesex, UKhttps://orcid.org/0000-0002-2263-1407
https://orcid.org/0000-0002-2263-1407, Necdet B Gunsoy3 Value Evidence and Outcomes, GSK, Uxbridge, Middlesex, UKhttps://orcid.org/0000-0003-1298-2462
https://orcid.org/0000-0003-1298-2462, , Nancy Risebrough5 ICON Health Economics, ICON, Toronto, ON, Canadahttps://orcid.org/0000-0001-6572-3021
https://orcid.org/0000-0001-6572-3021, & Afisi S Ismaila7 Value Evidence & Outcomes, GSK, Collegeville, PA, USA;8 Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, CanadaCorrespondence[email protected]
https://orcid.org/0000-0002-2876-8308
https://orcid.org/0000-0002-2876-8308 show all